Benoit Barteau
Directeur/Membre du Conseil chez Dynacure SA
Provenance du réseau au premier degré de Benoit Barteau
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
53
| Subsidiary | Investment Managers | 53 |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.
13
| Subsidiary | Medical/Nursing Services | 13 |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Benoit Barteau via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
CDC Enterprises, Inc.
 CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL. | Electrical Products | Chief Investment Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| MERSEN | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
| EOS IMAGING | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal Chief Executive Officer | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
| EUTELSAT COMMUNICATIONS | Major Telecommunications | Director/Board Member Director/Board Member Director/Board Member | |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ORANGE | Wireless Telecommunications | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| FERMENTALG | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
CMA CGM SA
 CMA CGM SA Marine ShippingTransportation CMA CGM SA engages in the provision of shipping transportation services. It specializes in logistics, cargo storage, and handling solutions. The company was founded by Jacques Rodolphe Saadé in 1978 and is headquartered in Marseille, France. | Marine Shipping | Director/Board Member Director/Board Member | |
Total Eren SA
 Total Eren SA Financial ConglomeratesFinance Total Eren SA develops and invests in renewable energy projects. It constructs solar panel and wind turbine farms. The company was founded by Pâris Mouratoglou and David Corchia in 2012 and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| CAPGEMINI SE | Information Technology Services | Director of Finance/CFO Corporate Officer/Principal | |
| ABEO SA | Recreational Products | Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
Bpifrance SA
 Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Chief Executive Officer Director/Board Member | |
Banque Publique d'Investissement
 Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | Finance/Rental/Leasing | Chief Executive Officer Corporate Officer/Principal | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BASTIDE LE CONFORT MÉDICAL | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| VERGNET S.A. | Electrical Products | Director/Board Member Director/Board Member | |
FT1CI
 FT1CI Other Metals/MineralsNon-Energy Minerals FT1CI provides services to nuclear power plants such as uranium mining and fuel production, maintenance and engineering services, recycling and processing of nuclear waste, and manufactures nuclear power generation, transmission and distribution equipment. It is headquartered in Paris, France. | Other Metals/Minerals | Chief Executive Officer Director/Board Member | |
| EM Lyon Business School | College/University | Graduate Degree Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree | |
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiques
Internationale
| France | 48 |
| Etats-Unis | 3 |
| Suisse | 2 |
Sectorielle
| Health Technology | 21 |
| Finance | 9 |
| Consumer Services | 7 |
| Health Services | 4 |
| Producer Manufacturing | 4 |
Opérationnelle
| Director/Board Member | 470 |
| Corporate Officer/Principal | 71 |
| Private Equity Investor | 62 |
| Chairman | 49 |
| Independent Dir/Board Member | 35 |
Relations les plus connectées
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 65 |
| Nicolas Dufourcq | 53 |
| Raphaël Wisniewski | 45 |
| Vanessa Giraud | 41 |
| Georges Gemayel | 33 |
| Henry Skinner | 29 |
| Rémi Droller | 29 |
| Chris Mirabelli | 29 |
| Chahra Khaoua Epouse Louafi | 26 |
| Philippe Boucheron | 24 |
| Laurent Arthaud | 21 |
| Maïlys Ferrère | 21 |
| Marie-Laure Garrigues | 19 |
| Olivier Martinez | 19 |
| Paul-François Fournier | 18 |
- Bourse
- Insiders
- Benoit Barteau
- Connexions Sociétés
